Home › Funds › Englebert Financial Advisers, LLC › SOLV

Englebert Financial Advisers, LLC position in SOLV

SOLVENTUM CORP · Health Care

Englebert Financial Advisers, LLC reported holding 9,857 shares of SOLV (SOLVENTUM CORP) in its Q2 2026 13F filing — a position valued at US$760K, representing 0.76% of its reported portfolio and ranking #25 among its reported holdings. Englebert Financial Advisers, LLC has disclosed SOLV holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)9.86K sh
Reported value held$760.47K
Portfolio Weight0.76%
First reportedQ4 2025
Last changeNew

How Englebert Financial Advisers, LLC's SOLV position evolved

Englebert Financial Advisers, LLC first disclosed a stake in SOLV in Q4 2025 at 10,088 shares (US$799K). Across 3 filings, Englebert Financial Advisers, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 9,857 shares valued at US$760K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 10.09K $799.37K New
Q1 2026 9.79K $639.22K Reduce
Q2 2026 9.86K $760.47K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SOLV and 13F data

SOLV (SOLVENTUM CORP) is a Health Care company. 45 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.25B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$486.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOLV

All SOLV fund holders →